Clearmind Medicine (CMND) said Wednesday it has received a Nasdaq notice stating it has regained compliance with the exchange's minimum bid price requirement.
The notice stated the closing bid price of the company's common shares was at $1 per share or greater for 10 business days from Dec. 15 through Dec. 29, the company said.
Price: 1.90, Change: +0.04, Percent Change: +2.20